Aurigene oncology limited announces promising results of phase 1 study for india's first trial for novel autologous car-t cell therapy for multiple myeloma

Bengaluru, india & hyderabad, india--(business wire)-- #aurigeneoncology--aurigene oncology announces promising results of phase 1 study for india's first trial for novel autologous car-t cell therapy for multiple myeloma.
RDY Ratings Summary
RDY Quant Ranking